Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 25;4(2):479-487.
doi: 10.1021/acsptsci.0c00189. eCollection 2021 Apr 9.

Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking

Affiliations

Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking

Eline Pottie et al. ACS Pharmacol Transl Sci. .

Abstract

Serotonergic psychedelics are defined as compounds having serotonin 2A receptor (5-HT2AR) activation as an important pharmacological mechanism. These compounds include the phenylalkylamine class, containing substances with e.g. 2C-X structures (phenethylamines) or their N-methoxybenzyl analogues (NBOMes). Besides their abuse potential, psychedelics are increasingly recognized for having therapeutic benefits. However, many psychedelics remain incompletely characterized, even concerning their structure-activity relationships. Here, five positional isomers of 25H-NBOMe, with two methoxy groups on the different positions of the phenyl ring of the phenethylamine moiety, were subjected to split-nanoluciferase assays assessing the in vitro recruitment of cytosolic proteins to the 5-HT2AR. Furthermore, molecular docking at the 5-HT2AR allowed estimation of which residues interact with the specific isomers' methoxy groups. Although the optimal substitution pattern of N-unsubstituted phenylalkylamines has been extensively studied, this is the first comparative evaluation of the functional effects of the positioning of the methoxy groups in the phenethylamine moiety of NBOMes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Structures of the substances tested in the 5-HT2AR bioassays: the reference substances LSD and serotonin and the “conventionally substituted” 25H-NBOMe, together with the five tested positional isomers. The numbers in the name of the positional isomer correspond to the methoxy group positions in the phenethylamine fragment, e.g. 25H-NBOMe has one methoxy group at position 2 and one methoxy group at position 5.
Figure 2
Figure 2
Concentration–response curves obtained by stimulation of the 5-HT2AR followed by recruitment of (A and C) βarr2 or (B and D) miniGαq constructs in the NanoBiT system. Data points are given as the mean of three independent experiments (each performed in duplicate) ± SEM (standard error of the mean). The AUC is normalized in each independent experiment for the maximum response (100%) of the reference agonist LSD (A and B) or serotonin (C and D).
Figure 3
Figure 3
Visual representations of the NBOMe isomers docked into the binding pocket of the 5-HT2AR (based on PDB: 6WHA). (A) 24H-NBOMe, as seen from the perspective of the N-benzyl moiety; (B) 24H-NBOMe and (C) 35H-NBOMe bound to the 5-HT2AR looking from the perspective of the phenyl group, with specific mentioning of the residues proposed to interact with the methoxy groups on the phenethylamine moiety.

References

    1. Nichols D. E. (2004) Hallucinogens. Pharmacol. Ther. 101, 131–181. 10.1016/j.pharmthera.2003.11.002. - DOI - PubMed
    1. Nichols D. E. (2017) Chemistry and Structure-Activity Relationships of Psychedelics. Curr. Top. Behav. Neurosci. 36, 1–43. 10.1007/7854_2017_475. - DOI - PubMed
    1. Poulie C. B. M.; Jensen A. A.; Halberstadt A. L.; Kristensen J. L. (2020) DARK Classics in Chemical Neuroscience: NBOMes. ACS Chem. Neurosci. 11, 3860.10.1021/acschemneuro.9b00528. - DOI - PMC - PubMed
    1. UNODC . Current NPS Threats, 2020. https://www.unodc.org/unodc/en/scientists/current-nps-threats.html (accessed September 2020).
    1. Kyriakou C.; Marinelli E.; Frati P.; Santurro A.; Afxentiou M.; Zaami S.; Busardo F. P. (2015) NBOMe: new potent hallucinogens--pharmacology, analytical methods, toxicities, fatalities: a review. Eur. Rev. Med. Pharmacol. Sci. 19, 3270–3281. - PubMed